
Patients with AFib have irregular heart rhythms that cause inefficient blood flow, leading to blood clot formation in the LAA. If a clot dislodges, it can travel to the brain and cause a stroke. To manage this risk, many AFib patients take anticoagulants (blood thinners), but these medications can have serious side effects, including:
✅ Increased bleeding risk (especially in older adults)
✅ Gastrointestinal bleeding complications
✅ Difficulty in long-term medication adherence
For patients who cannot take blood thinners due to these risks, LAAO offers an effective alternative to prevent strokes.
LAAO is performed using a catheter-based, minimally invasive technique under general anesthesia or conscious sedation. The step-by-step process includes:
Catheter Insertion: A thin catheter is inserted through the femoral vein in the groin and guided to the heart.
Transseptal Puncture: A small puncture is made in the interatrial septum to access the left atrium.
Device Placement: A specialized occlusion device (e.g., WATCHMAN™, Amplatzer™ Amulet) is deployed in the left atrial appendage, sealing it off.
Verification: Imaging techniques such as transesophageal echocardiography (TEE) confirm proper placement.
Healing & Endothelialization: Over time, heart tissue grows over the device, permanently sealing the LAA.
🔹 Atrial fibrillation treatment without blood thinners
🔹 Left atrial appendage occlusion procedure
🔹 Stroke prevention in AFib patients
🔹 WATCHMAN™ device for atrial fibrillation
🔹 Alternatives to blood thinners for AFib
🔹 Minimally invasive heart procedures
🔹 AFib stroke prevention options